| 注册
首页|期刊导航|空军军医大学学报|胃癌化学预防:阿司匹林、二甲双胍等经典药物的希望与挑战

胃癌化学预防:阿司匹林、二甲双胍等经典药物的希望与挑战

李嵩博 时永全

空军军医大学学报2026,Vol.47Issue(6):781-789,9.
空军军医大学学报2026,Vol.47Issue(6):781-789,9.DOI:10.13276/j.issn.2097-1656.2026.06.001

胃癌化学预防:阿司匹林、二甲双胍等经典药物的希望与挑战

Gastric cancer chemoprevention:hopes and challenges of aspirin,metformin,and other classic drugs

李嵩博 1时永全1

作者信息

  • 1. 空军军医大学西京医院消化内科,国家消化系统疾病临床医学研究中心,消化系肿瘤整合防治全国重点实验室,陕西西安 710032
  • 折叠

摘要

Abstract

Gastric cancer is one of the most common malignant neoplasms worldwide,with nearly half of all new cases and deaths occurring in China annually.Helicobacter pylori(Hp)infection is a major risk factor for gastric cancer;however,Hp eradication does not completely prevent the occurrence of gastric cancer.In recent years,the relationship between aspirin,cyclooxygenase-2 inhibitors,metformin,and statins and the risk of gastric cancer has garnered substantial attention.The epidemiological evidence,potential mechanisms of action,and clinical translation prospects of these drugs in relation to gastric cancer risk are systematically reviewed,and future research directions are proposed.

关键词

胃肿瘤/化学预防/阿司匹林/环氧化酶2抑制剂/二甲双胍/羟甲基戊二酰辅酶A还原酶抑制剂/幽门螺杆菌/危险因素

Key words

stomach neoplasms/chemoprevention/aspirin/cyclooxygenase-2 inhibitors/metformin/hydroxymethylglutaryl-CoA reductase inhibitors/Helicobacter pylori/risk factors

分类

医药卫生

引用本文复制引用

李嵩博,时永全..胃癌化学预防:阿司匹林、二甲双胍等经典药物的希望与挑战[J].空军军医大学学报,2026,47(6):781-789,9.

基金项目

国家科技重大专项(2025ZD0545301) (2025ZD0545301)

陕西省卫生健康科研创新能力提升计划团队支持项目(2024TD-06) (2024TD-06)

空军军医大学学报

OACHSSCD

2097-1656

访问量0
|
下载量0
段落导航相关论文